The corporate venturing unit has launched a second fund, just over three years after putting $100m into its first.

The University of Warwick spinout is developing treatments for respiratory conditions such as influenza.

Takeda Ventures has hired Jayson Punwani from Pappas Ventures as an investment director.

The GV-backed immunotherapy developer has filed for a $57.5m initial public offering that will come after $95m of venture financing.

Dah Chong Hong will join forces with parent company Citic Pacific to form an $80m healthcare and consumer-focused vehicle dubbed Tamar Alliance Fund.

Quest Diagnostics will acquire Cleveland HeartLab, a cardiac diagnostics test provider spun out of Cleveland Clinic, or an undisclosed sum.

AstraZeneca has returned to back a $200m private placement for cancer drug developer ADC Therapeutics, which has now raised a total of $455m.

The hearing aid developer has raised $32.4m from investors including Nan Fung Life Sciences for the first close of its series C round.

Infectious and respiratory disease drug developer Vir Biotechnology said it has now raised more than $500m from investors such as SoftBank Vision Fund.